EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieKlinische Studie (Phase III)

Phase 3 Trial of Epicutaneous Immunotherapy in Toddlers with Peanut Allergy

Matthew Greenhawt, Sayantani B Sindher, Julie Wang, Michael O'Sullivan, George du Toit, Edwin H Kim, Deborah Albright, Sara Anvari, Nicolette Arends, Peter D Arkwright iD, Philippe Bégin, Katharina Blumchen und 48 weitere

New England Journal of Medicine · 11.05.2023 · 388 (19) · 1755-1766

DOI: 10.1056/nejmoa2212895 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift New England Journal of Medicine, erschienen am 11.05.2023. Verfasst von Matthew Greenhawt und 59 weiteren Autor:innen. Beteiligte Einrichtung: From the Section of Allergy and Immunology, Department of Pediatrics, Children's Hospital Colorado, University of Colorado School of Medicine, Aurora…. Hauptthemen laut MEDLINE: Anaphylaxis, Desensitization, Immunologic, Peanut Hypersensitivity. Die Arbeit wurde bisher 137-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: DBV Technologies.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnaphylaxisDesensitization, ImmunologicPeanut HypersensitivityChild, PreschoolHumansInfantAllergensArachisAdministration, Cutaneous

Substanzen

Allergens

Autor:innen und Institutionen

  • From the Section of Allergy and Immunology, Department of Pediatrics, Children's Hospital Colorado, University of Colorado School of Medicine, Aurora (M.G., D.M.F.); the Sean N. Parker Center for Allergy and Asthma Rese…

ORCID-Profile: Peter D Arkwright, Morna J Dorsey, Christopher Parrish, Julia E Upton

Förderung

  • DBV Technologies

Zitieren

APA

Greenhawt, M., Sindher, S. B., Wang, J., O'Sullivan, M., du Toit, G., Kim, E. H., Albright, D., Anvari, S., Arends, N., Arkwright, P. D., Bégin, P., Blumchen, K., Bourrier, T., Brown-Whitehorn, T., Cassell, H., Chan, E. S., Ciaccio, C. E., Deschildre, A., Divaret-Chauveau, A., …, & Green, T. D. (2023). Phase 3 Trial of Epicutaneous Immunotherapy in Toddlers with Peanut Allergy. New England Journal of Medicine, 388(19), 1755-1766. https://doi.org/10.1056/nejmoa2212895

Vancouver

Greenhawt M, Sindher SB, Wang J, O'Sullivan M, du Toit G, Kim EH, et al. Phase 3 Trial of Epicutaneous Immunotherapy in Toddlers with Peanut Allergy. New England Journal of Medicine. 2023;388(19):1755-1766. doi:10.1056/nejmoa2212895

BibTeX
@article{Greenhawt2023,
  author = {Greenhawt, Matthew and Sindher, Sayantani B and Wang, Julie and O'Sullivan, Michael and du Toit, George and Kim, Edwin H and Albright, Deborah and Anvari, Sara and Arends, Nicolette and Arkwright, Peter D and Bégin, Philippe and Blumchen, Katharina and Bourrier, Thierry and Brown-Whitehorn, Terri and Cassell, Heather and Chan, Edmond S and Ciaccio, Christina E and Deschildre, Antoine and Divaret-Chauveau, Amandine and Dorris, Stacy L and Dorsey, Morna J and Eiwegger, Thomas and Erlewyn-Lajeunesse, Michel and Fleischer, David M and Ford, Lara S and Garcia-Lloret, Maria and Giovannini-Chami, Lisa and Hourihane, Jonathan O and Jay, Nicola and Jones, Stacie M and Kerns, Leigh Ann and Kloepfer, Kirsten M and Leonard, Stephanie and Lezmi, Guillaume and Lieberman, Jay A and Lomas, Jeanne and Makhija, Melanie and Parrish, Christopher and Peake, Jane and Perrett, Kirsten P and Petroni, Daniel and Pfützner, Wolfgang and Pongracic, Jacqueline A and Quinn, Patrick and Robison, Rachel G and Sanders, Georgiana and Schneider, Lynda and Sharma, Hemant P and Trujillo, Juan and Turner, Paul J and Tuttle, Katherine and Upton, Julia E and Varshney, Pooja and Vickery, Brian P and Vogelberg, Christian and Wainstein, Brynn and Wood, Robert A and Bee, Katharine J and Campbell, Dianne E and Green, Todd D},
  title = {Phase 3 Trial of Epicutaneous Immunotherapy in Toddlers with Peanut Allergy},
  journal = {New England Journal of Medicine},
  year = {2023},
  volume = {388},
  number = {19},
  pages = {1755--1766},
  doi = {10.1056/nejmoa2212895}
}
Kostenlos starten →